Press release article from our research archive:
|
|
Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs.
- Article from:
-
PR Newswire
- Article date:
-
June 25, 2008
|
Copyright informationCOPYRIGHT 2008 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
EAST SETAUKET, N.Y., June 25 /PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings (BULLETIN BOARD: LIXT) announced today that the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH) and Lixte Biotechnology Holdings, Inc. extended their Cooperative Research and Development Agreement (CRADA) to develop drugs for the treatment of brain cancers. The CRADA, initiated in March 2006 was extended through September 2009.
Dr. John S. Kovach, President and CEO of Lixte, said, "The scientific interaction with the research team at the Molecular Pathogenesis Unit (MPU), Surgical Neurology Branch, (SNB), NINDS, has been highly ...
Related newspaper, magazine, and journal articles:
|
RealPennies.com: Turning Pennies into dollars: (OTCBB:LIXT) Lixte...
M2 Presswire;
August 8, 2008 ;
700+ words
......OTCBB:LIXT) Lixte Biotechnology, Inc.(C)1994-20...lixt.html Lixte Biotechnology Holdings...Aug. 8 - Lixte Biotechnology Holdings...cancer. About Lixte Biotechnology Holdings, Inc.: Lixte Biotechnology Holdings...in 2005, Lixte develops...cancers. ...
|
|
Lixte Biotechnology Holdings Announces That Novel Compounds Being...
PR Newswire;
August 8, 2008 ;
542 words
......PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings...cancer. About Lixte Biotechnology Holdings, Inc.: Lixte Biotechnology Holdings...in 2005, Lixte develops...cancers. Forward-Looking Statements: This announcement...contains certain ...
|
|
|
Lixte Biotechnology Holdings, Inc. Announces Completion of Private...
PR Newswire;
December 18, 2007 ;
700+ words
......PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings, Inc. (BULLETIN...advisory services. Forward-Looking Statements This announcement contains certain forward-looking statements within the meaning...pricing factors are all forward-looking ...
|
|
|
Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its...
PR Newswire;
September 24, 2007 ;
700+ words
......PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings, Inc...independently. About Lixte Biotechnology Holdings, Inc.: Lixte Biotechnology Holdings, Inc...www.nih.gov/. Forward-Looking Statements This announcement contains certain forward-looking ...
|
|
|
Lixte Biotechnology Holdings, Inc. Announces Further Developments...
PR Newswire;
February 26, 2008 ;
700+ words
......PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings, Inc...diseases. About Lixte Biotechnology Holdings, Inc.: Lixte Biotechnology Holdings, Inc...www.nih.gov/. Forward-Looking Statements This announcement contains certain forward-looking ...
|
|
|
Lixte Biotechnology Holdings Inc. Receives Attention.
M2 Presswire;
April 24, 2008 ;
700+ words
......2008-BMJ Financial Edition: Lixte Biotechnology Holdings Inc. Receives...Today, we began tracking Lixte Biotechnology Holdings Inc. (OTC BB...Wednesday, April 23, 2008, Lixte Biotechnology Holdings announced today...and its collaborator, Lixte Biotechnology Holdings. ...
|
|
|
Has added Lixte Biotechnology Holdings, Inc. to their watch list.
M2 Presswire;
February 26, 2008 ;
700+ words
......Group: Has added Lixte Biotechnology Holdings, Inc...activity has brought Lixte Biotechnology Holdings, Inc...February 26, 2008, Lixte Biotechnology Holdings, Inc...February 26, 2008, Lixte Biotechnology Holdings, Inc...release may include forward-looking ...
|
|
|
Lixte Biotechnology Holdings Inc. Review in Progress.
M2 Presswire;
April 24, 2008 ;
700+ words
......PRESSWIRE-24 April 2008-MG Strategies: Lixte Biotechnology Holdings Inc. Review in Progress...Wednesday, April 23, 2008, we have added Lixte Biotechnology Holdings Inc. (OTC BB: LIXT) to...numerous publicly traded companies Lixte Biotechnology Holdings Inc. was a flat trader...
|
|
|
Lixte Biotechnology Holdings Announces New Appointment To Board Of...
PR Newswire;
November 29, 2007 ;
700+ words
......Directors and CEO of Lixte Biotechnology Holdings, Inc. (BULLETIN...companies. He brings Lixte a wealth of experience...governance. We very much look forward to working with him stated Dr. Kovach. About Lixte Biotechnology Holdings, Inc.: Lixte Biotechnology Holdings, ...
|
|
|
Lixte Biotechnology Holdings Announces New Appointment to Board of...
PR Newswire;
October 20, 2008 ;
700+ words
......Chair, Board of Directors and CEO of Lixte Biotechnology Holdings, Inc. (BULLETIN BOARD...that Dr. Sorensen has joined the Lixte Biotechnology board of directors. Mel is internationally...with him, stated Dr. Kovach. About Lixte Biotechnology Holdings, Inc.: Lixte is a ...
|
|
|
Examine this Essential and Comprehensive Report Examining Brain Tumors...
M2 Presswire;
November 6, 2008 ;
515 words
......Corporation --BioWa, Inc. --Cylene Pharmaceuticals, Inc. --Cephalon Inc --ESBATech AG --Diffusion Pharmaceuticals LLC --Lixte Biotechnology Holdings, Inc. --Kyowa Hakko Kogyo Co., Ltd. --Merck & Co Inc --MediGene AG --NeuroSearch A/S --NatImmune A/S --Targepeutics...
|
See all results.
Or, try our
Advanced Search.
|